RobertoPecoits Filho United StatesArbor Research Collaborative for Health

Dr. Pecoits-Filho is a Distinguished Research Scientist at Arbor Research Collaborative for Health in Michigan, USA and a Professor of Medicine, Pontifical Catholic University of Paraná in Curitiba, Brazil. He is the current Deputy Chair of the International Society of Nephrology iNET-CKD. Dr. Pecoits-Filho is the Scientific Director of the DOPPS Program, a multinational study on practice patterns and outcomes in chronic kidney disease, hemodialysis and peritoneal dialysis and act as a Scientific Leader for clinical trials in the Americas with George Clinical. Dr. Pecoits-Filho served as a member of the Executive Committee of the International Society of Nephrology (ISN) (2017-2019), the SONG Initiative (2017-present) and KDIGO (2016-2018).

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/c54256c33fbba7d732f62560ad2d5efc.jpg

First name

Roberto

Last name

Pecoits Filho

Institution

Country

United States

Friday, February 7, 2025

Time	Session

2:15 p.m. 3:45 p.m.	Improving Global Understanding and Achieving Equity in Peritoneal Dialysis Practices: ISN-DOPPS Joint Session LF2001 AmitGupta Chair IndiaChairman Department of Nephrology & Renal Transplantation, Apollomedics Superspeciality Hospital, Lucknow, India RitaSuri Chair CanadaMcGill University RobertoPecoits Filho Chair United StatesArbor Research Collaborative for Health PDOPPS: Where Are We 10 Years Later? LF2001-01 RobertoPecoits Filho Speaker United StatesArbor Research Collaborative for Health Kidney Health for Women on Peritoneal Dialysis: Insights from PDOPPS LF2001-02 EdwinaBrown Speaker United KingdomImperial College Healthcare NHS Trust Was the PD-First Policy in Thailand Justified? Insights From the PDOPPS LF2001-03 TalerngsakKanjanabuch Speaker ThailandFaculty of Medicine, Chulalongkorn University Improving PD Use and Outcomes in Low and Middle-income Countries - Is Automated Peritoneal Dialysis the Answer? Yes LF2001-04 JeffreyPerl Speaker CanadaSt. Michael's Hospital Improving PD Use and Outcomes in Low and Middle-income Countries - Is Automated Peritoneal Dialysis the Answer? No LF2001-05 RashaDarwish Speaker EgyptKasr Aleiny medical school , Cairo University Q&A/Panel Discussion LF2001-06 Gulmohar Hall 302

Time

Session

2:15 p.m.

3:45 p.m.

Improving Global Understanding and Achieving Equity in Peritoneal Dialysis Practices: ISN-DOPPS Joint Session

LF2001

AmitGupta Chair IndiaChairman Department of Nephrology & Renal Transplantation, Apollomedics Superspeciality Hospital, Lucknow, India

RitaSuri Chair CanadaMcGill University

RobertoPecoits Filho Chair United StatesArbor Research Collaborative for Health

PDOPPS: Where Are We 10 Years Later?

LF2001-01

RobertoPecoits Filho Speaker United StatesArbor Research Collaborative for Health
Kidney Health for Women on Peritoneal Dialysis: Insights from PDOPPS

LF2001-02

EdwinaBrown Speaker United KingdomImperial College Healthcare NHS Trust
Was the PD-First Policy in Thailand Justified? Insights From the PDOPPS

LF2001-03

TalerngsakKanjanabuch Speaker ThailandFaculty of Medicine, Chulalongkorn University
Improving PD Use and Outcomes in Low and Middle-income Countries - Is Automated Peritoneal Dialysis the Answer? Yes

LF2001-04

JeffreyPerl Speaker CanadaSt. Michael's Hospital
Improving PD Use and Outcomes in Low and Middle-income Countries - Is Automated Peritoneal Dialysis the Answer? No

LF2001-05

RashaDarwish Speaker EgyptKasr Aleiny medical school , Cairo University
Q&A/Panel Discussion

LF2001-06

Gulmohar Hall 302

Saturday, February 8, 2025

Time	Session

11:15 a.m. 11:45 a.m.	Inside iNET-CKD: Uncovering the Power of Cohort Studies to Understand Ckd Progression and Complications SL11 MaartenTaal Spotlight Chairperson United KingdomUniversity of Nottingham RobertoPecoits Filho Spotlight Chairperson United StatesArbor Research Collaborative for Health Introducing iNET-CKD: Harnessing Global Cohorts to Transform CKD Research MaartenTaal Spotlight Speaker United KingdomUniversity of Nottingham Exploring iNET-CKD Cohorts: Key Findings from iNET-CKD Studies RobertoPecoits Filho Spotlight Speaker United StatesArbor Research Collaborative for Health Collaborative Opportunities in CKD Research: Leveraging the iNET-CKD Platform AdeeraLevin Spotlight Speaker CanadaUniversity of British Columbia and Providence Health Care Q and A Spotlight One (Exhibition)
2:15 p.m. 3:45 p.m.	What’s Next in Kidney Care Research? Innovations and Clinical Trials on the Horizon SS2 AdeeraLevin Chair CanadaUniversity of British Columbia and Providence Health Care AndreaViecelli Chair AustraliaUniversity of Queensland Ajit singhNarula Chair India Novel Trial Designs in Nephrology: Innovations and Structures SS2-01 MegJardine Speaker AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia What’s New in Clinical Trials? SS2-02 DavidWheeler Speaker United KingdomUniversity College London Value of Different Outcomes in the Era of Precision Medicine SS2-03 RobertoPecoits Filho Speaker United StatesArbor Research Collaborative for Health Conducting Trials in Low and Middle-income Countries SS2-04 SoumitaBagchi Speaker IndiaProfessor, Department of Nephrology, All India Institute of Medical Sciences, New Delhi Innovations in Pediatric Nephrology Discovery and Clinical Trial Conduct SS2-05 ArpanaIyengar Speaker IndiaST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALORE Q&A SS2-06 Parijat Hall 201
4:15 p.m. 5:15 p.m.	Connecting Cardio-Kidney-Metabolic Dots: Holistic Approaches to Patient Care IK1002 Denis GeorgesTeuwafeu Chair CameroonUniversity of Buea, Faculty of Health Sciences RobertKalyesubula Chair UgandaMakerere, University RobertoPecoits Filho Chair United StatesArbor Research Collaborative for Health A Nephrologist Perspective on the Cardio-Kidney-Metabolic Syndrome IK1002-01 JananiRangaswami Speaker United StatesProfessor of Medicine, George Washington University School of Medicine Optimizing CKD Management in the Context of Diabetes and Obesity IK1002-02 RobertoPecoits Filho Speaker United StatesArbor Research Collaborative for Health Combining Therapies for Cardio-Kidney-Metabolic Conditions: An Integrative Approach IK1002-03 KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology Q&A IK1002-04 Champa Hall 304